Titan Pharmaceuticals Profit Margin 2006-2021 | TTNP
Current and historical gross margin, operating margin and net profit margin for Titan Pharmaceuticals (TTNP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Titan Pharmaceuticals net profit margin as of June 30, 2021 is -343.68%.
|Titan Pharmaceuticals Annual Profit Margins
|Titan Pharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.